Octanoic acid
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
87 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Immunologic deficiency syndromes | D007153 | — | D84.9 | — | 1 | 3 | 2 | 1 | 7 |
| Primary immunodeficiency diseases | D000081207 | — | — | — | 1 | 2 | 2 | 1 | 6 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 1 | — | 1 | 2 | 5 |
| Peripheral nervous system diseases | D010523 | — | G64 | — | 2 | — | 1 | — | 3 |
| Aging | D000375 | GO_0007568 | R41.81 | — | — | — | 1 | 1 | 2 |
| Polyneuropathies | D011115 | EFO_0009562 | A69.22 | — | — | 1 | 1 | — | 2 |
| Chronic inflammatory demyelinating polyradiculoneuropathy | D020277 | EFO_1000868 | G61.81 | — | — | 1 | 1 | — | 2 |
| Septic shock | D012772 | — | A48.3 | — | — | — | 1 | — | 1 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | 1 | — | 1 |
| Shock | D012769 | — | R57.1 | — | — | — | 1 | — | 1 |
Show 9 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Syndrome | D013577 | — | — | 1 | 3 | 1 | — | 1 | 5 |
| Myasthenia gravis | D009157 | EFO_0004991 | G70.0 | — | 1 | 1 | — | — | 2 |
| Muscle weakness | D018908 | — | — | — | 1 | 1 | — | — | 2 |
| Agammaglobulinemia | D000361 | — | D80.1 | — | 1 | 1 | — | — | 2 |
| Hallux valgus | D006215 | — | — | — | 1 | 1 | — | — | 1 |
| Hallux rigidus | D020859 | — | M20.2 | — | 1 | 1 | — | — | 1 |
| Hallux limitus | D020857 | — | — | — | 1 | 1 | — | — | 1 |
| Polyradiculoneuropathy | D011129 | EFO_1001116 | — | — | — | 1 | — | — | 1 |
| Wiskott-aldrich syndrome | D014923 | EFO_0003903 | D82.0 | — | — | 1 | — | — | 1 |
| Severe combined immunodeficiency | D016511 | — | D81.0 | — | — | 1 | — | — | 1 |
Show 1 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 4 | 2 | — | — | — | 5 |
| Gastroparesis | D018589 | EFO_1000948 | K31.84 | — | 2 | — | — | 2 | 4 |
| Adenocarcinoma | D000230 | — | — | 3 | 1 | — | — | — | 4 |
| Recurrence | D012008 | — | — | 4 | 1 | — | — | — | 4 |
| Myelodysplastic syndromes | D009190 | — | D46 | 1 | 3 | — | — | — | 3 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 2 | 2 | — | — | — | 3 |
| Myeloid leukemia | D007951 | — | C92 | 2 | 2 | — | — | — | 3 |
| Preleukemia | D011289 | — | — | 1 | 3 | — | — | — | 3 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | 1 | — | — | — | 3 |
| Essential tremor | D020329 | EFO_0003108 | G25.0 | 3 | 2 | — | — | — | 3 |
Show 34 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | 3 | 5 |
| Pancreatic ductal carcinoma | D021441 | — | — | 2 | — | — | — | — | 2 |
| Acinar cell carcinoma | D018267 | — | — | 2 | — | — | — | — | 2 |
| Mycoses | D009181 | — | B35-B49 | 2 | — | — | — | — | 2 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | — | — | — | — | 2 |
| Lymphoma | D008223 | — | C85.9 | 2 | — | — | — | — | 2 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 2 | — | — | — | — | 2 |
| Sezary syndrome | D012751 | — | C84.1 | 2 | — | — | — | — | 2 |
| Biphenotypic leukemia acute | D015456 | — | C95.0 | 2 | — | — | — | — | 2 |
| Mycosis fungoides | D009182 | — | C84.0 | 2 | — | — | — | — | 2 |
Show 38 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 2 | 2 |
| Skin aging | D015595 | EFO_0005422 | — | — | — | — | — | 2 | 2 |
| Ketosis | D007662 | — | R82.4 | — | — | — | — | 1 | 1 |
| Satiety response | D012528 | — | — | — | — | — | — | 1 | 1 |
| Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | — | 1 | 1 |
| Gastric emptying | D005746 | — | — | — | — | — | — | 1 | 1 |
| Skin diseases | D012871 | — | L00-L99 | — | — | — | — | 1 | 1 |
| Hypoglycemia | D007003 | — | E16.2 | — | — | — | — | 1 | 1 |
| Microbiota | D064307 | — | — | — | — | — | — | 1 | 1 |
| Diabetic foot | D017719 | EFO_1001459 | — | — | — | — | — | 1 | 1 |
Show 10 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 13,088 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
19 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use